The International Serious Adverse Events Consortium's data sharing model.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 23302924)

Published in Nat Biotechnol on January 01, 2013

Authors

Jorge L Contreras, Aris Floratos, Arthur L Holden

Articles cited by this

The International HapMap Project. Nature (2003) 73.65

New models of collaboration in genome-wide association studies: the Genetic Association Information Network. Nat Genet (2007) 13.76

Charting a course for genomic medicine from base pairs to bedside. Nature (2011) 9.39

Data sharing in genomics--re-shaping scientific practice. Nat Rev Genet (2009) 5.83

International Cancer Genome Consortium Data Portal--a one-stop shop for cancer genomics data. Database (Oxford) (2011) 4.53

HLA-B*5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin. Nat Genet (2009) 4.11

Case definition and phenotype standardization in drug-induced liver injury. Clin Pharmacol Ther (2011) 2.50

Susceptibility to amoxicillin-clavulanate-induced liver injury is influenced by multiple HLA class I and II alleles. Gastroenterology (2011) 2.01

Ethical and practical challenges of sharing data from genome-wide association studies: the eMERGE Consortium experience. Genome Res (2011) 1.91

Data sharing and intellectual property in a genomic epidemiology network: policies for large-scale research collaboration. Bull World Health Organ (2006) 1.56

Information access. Prepublication data release, latency, and genome commons. Science (2010) 1.31

The phenotype standardization project: improving pharmacogenetic studies of serious adverse drug reactions. Clin Pharmacol Ther (2011) 1.12

The SNP consortium: summary of a private consortium effort to develop an applied map of the human genome. Biotechniques (2002) 1.10

Phenotype standardization for immune-mediated drug-induced skin injury. Clin Pharmacol Ther (2011) 1.10

dbGaP data access requests: a call for greater transparency. Sci Transl Med (2011) 1.09

Genome-wide association study of serious blistering skin rash caused by drugs. Pharmacogenomics J (2011) 0.91

Articles by these authors

A second generation human haplotype map of over 3.1 million SNPs. Nature (2007) 85.39

Genome-wide detection and characterization of positive selection in human populations. Nature (2007) 17.27

Prepublication data sharing. Nature (2009) 12.24

A 3.9-centimorgan-resolution human single-nucleotide polymorphism linkage map and screening set. Am J Hum Genet (2003) 5.34

HLA-B*5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin. Nat Genet (2009) 4.11

iTools: a framework for classification, categorization and integration of computational biology resources. PLoS One (2008) 2.18

Susceptibility to amoxicillin-clavulanate-induced liver injury is influenced by multiple HLA class I and II alleles. Gastroenterology (2011) 2.01

Linkage disequilibrium and inference of ancestral recombination in 538 single-nucleotide polymorphism clusters across the human genome. Am J Hum Genet (2003) 1.58

Genomewide pharmacogenetics of bisphosphonate-induced osteonecrosis of the jaw: the role of RBMS3. Oncologist (2012) 1.50

Limited contribution of common genetic variants to risk for liver injury due to a variety of drugs. Pharmacogenet Genomics (2012) 1.21

Dictionary-driven protein annotation. Nucleic Acids Res (2002) 1.08

Genome wide analysis of drug-induced torsades de pointes: lack of common variants with large effect sizes. PLoS One (2013) 1.04

Pattern-based mining strategy to detect multi-locus association and gene x environment interaction. BMC Proc (2007) 0.93

HLA-DRB1*16: 01-DQB1*05: 02 is a novel genetic risk factor for flupirtine-induced liver injury. Pharmacogenet Genomics (2016) 0.79

Legal issues for biological research standards. Nat Biotechnol (2008) 0.75